SPINK1 and pancreatitis: Recent preclinical studies in murine pancreatitis using an adeno-associated viral vector harboring the human SPINK1 cDNA offered proof of concept that gene therapy may be utilized to enhance pancreatic defenses against unwanted intrapancreatic trypsin activity and pancreatitis14.